Elacyt (elacytarabine) / Karo Pharma 
Welcome,         Profile    Billing    Logout  

1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Elacyt (elacytarabine) / Karo Pharma
ACTRN12611000474954: A Randomised Phase III Study of Elacytarabine vs. Investigator’s Choice in Patients with Late Stage Acute Myeloid Leukaemia

Recruiting
3
350
 
Clavis Pharma ASA, Clavis Pharma ASA
Relapsed / refractory AML
 
 

Download Options